{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:22:27Z","timestamp":1792264947186,"version":"4.4.0"},"reference-count":49,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2019283"],"award-info":[{"award-number":["2019283"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19YF1457300"],"award-info":[{"award-number":["19YF1457300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81521005"],"award-info":[{"award-number":["81521005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690265"],"award-info":[{"award-number":["81690265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903548"],"award-info":[{"award-number":["81903548"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA12050307"],"award-info":[{"award-number":["XDA12050307"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,15]]},"abstract":"<jats:title>Conspectus<\/jats:title>\n                  <jats:p>Cancer immunotherapy, which suppresses tumor relapse and metastasis by boosting host immunity and inducing long-term immune memory effects, is emerging as a vital approach to improve the prognosis of patients. Although remarkable efficacy has been observed in some patients, challenges including low response rate, drug resistance, and immune-related adverse effects still limit the clinical application of cancer immunotherapy in broad types of tumors. Immunotherapeutic agents are used to enhance tumor immunogenicity and reverse the effects of the immunosuppressive tumor microenvironment (ITM), but the benefits of monotherapy are mild and transient due to off-target distribution of drugs. To overcome these issues, smart nanosized drug delivery systems (sNDDS) have been developed to enhance tissue specificity, co-deliver multiple drugs, prime immune cells, and amplify immune responses in tumors. Moreover, accumulating knowledge in cancer biology, immunology, and material science has also greatly promoted the development of sNDDS for enhancing cancer immunotherapy.<\/jats:p>\n                  <jats:p>In this Account, we will discuss the approaches of our group in designing sNDDS to induce immunogenic cell death (ICD) for combination with cancer immunotherapy. We propose a brief overview on the design of nanocarriers, intelligent moieties and immunotherapeutic agents in sNDDS. Then, we discuss the strategies to remodel ITM by leveraging ICD as well as cooperating with programmed cell death protein 1 ligand blockade and indoleamine 2,3-dioxygenase 1 inhibition. We have synthesized a series of stimuli-responsive polymers and prodrugs to fabricate sNDDS and have integrated multiple immunotherapeutic drugs into one platform for combinational immunotherapy. Last, we present an outlook on future design of sNDDS and possible directions for enhancing cancer immunotherapy. Building on the concept of enhancing tumor immunogenicity and reversing ITM, we hope this Account will contribute to the rational design of sNDDS for co-delivery of multiple drugs with amplified immunotherapeutic efficacy.<\/jats:p>","DOI":"10.1021\/acs.accounts.0c00254","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T08:01:14Z","timestamp":1597996874000},"page":"1761-1772","source":"Crossref","is-referenced-by-count":106,"title":["Smart Nanosized Drug Delivery Systems Inducing Immunogenic\nCell Death for Combination with Cancer Immunotherapy"],"prefix":"10.1021","volume":"53","author":[{"given":"Lei","family":"Zhou","sequence":"first","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]},{"name":"China State Institute of Pharmaceutical Industry , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4546-0022","authenticated-orcid":true,"given":"Pengcheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]},{"name":"Yantai Institute of Materia Medica , , ,","place":["Shandong, China, 264000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"China State Institute of Pharmaceutical Industry , ,","place":["Shanghai, China, 201203"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dangge","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]},{"name":"Yantai Institute of Materia Medica , , ,","place":["Shandong, China, 264000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-6966","authenticated-orcid":true,"given":"Yaping","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences , , ,","place":["Shanghai, China, 201203"]},{"name":"Yantai Institute of Materia Medica , , ,","place":["Shandong, China, 264000"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"2026081806103698500_cit1","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1021\/acs.nanolett.9b01717","article-title":"Hepatocellular\nCarcinoma Growth Retardation\nand PD-1 Blockade Therapy Potentiation with Synthetic High-density\nLipoprotein","volume":"19","author":"Wang","year":"2019","journal-title":"Nano Lett."},{"key":"2026081806103698500_cit2","doi-asserted-by":"publisher","first-page":"eaau6584","DOI":"10.1126\/sciimmunol.aau6584","article-title":"Engineering nanoparticles\nto locally activate T cells in the tumor\nmicroenvironment","volume":"4","author":"Wang","year":"2019","journal-title":"Sci. Immunol."},{"key":"2026081806103698500_cit3","doi-asserted-by":"publisher","first-page":"1907210","DOI":"10.1002\/adma.201907210","article-title":"Engineering Stimuli-Activatable Boolean\nLogic Prodrug Nanoparticles for Combination Cancer Immunotherapy","volume":"32","author":"Hou","year":"2020","journal-title":"Adv. Mater."},{"key":"2026081806103698500_cit4","doi-asserted-by":"publisher","first-page":"1803001","DOI":"10.1002\/adma.201803001","article-title":"Binary\nCooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically\nModulating Immune Tumor Microenvironment","volume":"30","author":"Feng","year":"2018","journal-title":"Adv.\nMater."},{"key":"2026081806103698500_cit5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat\nimmune hot, altered and cold tumours with combination\nimmunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026081806103698500_cit6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.intimp.2018.06.001","article-title":"Immune\ncheckpoint blockade therapy\nfor cancer: An overview of FDA-approved immune checkpoint inhibitors","volume":"62","author":"Hargadon","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"2026081806103698500_cit7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrc3246","article-title":"The determinants\nof tumour immunogenicity","volume":"12","author":"Blankenstein","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"2026081806103698500_cit8","doi-asserted-by":"publisher","first-page":"1904156","DOI":"10.1002\/adma.201904156","article-title":"Nanomedicine-Based\nImmunotherapy for the Treatment of Cancer Metastasis","volume":"31","author":"Zhang","year":"2019","journal-title":"Adv. Mater."},{"key":"2026081806103698500_cit9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the\ntumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"2026081806103698500_cit10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.intimp.2018.06.001","article-title":"Immune checkpoint\nblockade therapy\nfor cancer: An overview of FDA-approved immune checkpoint inhibitors","volume":"62","author":"Hargadon","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"2026081806103698500_cit11","doi-asserted-by":"publisher","first-page":"100801","DOI":"10.1016\/j.nantod.2019.100801","article-title":"Recent\nadvances\nin nanosized drug delivery systems for overcoming the barriers to\nanti-PD immunotherapy of cancer","volume":"29","author":"Liu","year":"2019","journal-title":"Nano Today"},{"key":"2026081806103698500_cit12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41401-019-0281-1","article-title":"Overview of recent\nadvances in liposomal nanoparticle-based cancer\nimmunotherapy","volume":"40","author":"Gao","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"2026081806103698500_cit13","doi-asserted-by":"publisher","first-page":"1900101","DOI":"10.1002\/advs.201900101","article-title":"Immunomodulatory\nNanosystems","volume":"6","author":"Feng","year":"2019","journal-title":"Adv. Sci."},{"key":"2026081806103698500_cit14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41467-018-03915-4","article-title":"A cancer vaccine-mediated\npostoperative immunotherapy for recurrent and metastatic tumors","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"2026081806103698500_cit15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving\ncancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"2026081806103698500_cit16","doi-asserted-by":"publisher","first-page":"3702518","DOI":"10.1155\/2019\/3702518","article-title":"Smart Nanoparticles\nfor Drug Delivery\nApplication: Development of Versatile Nanocarrier Platforms in Biotechnology\nand Nanomedicine","volume":"2019","author":"Lombardo","year":"2019","journal-title":"J. Nanomater."},{"key":"2026081806103698500_cit17","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-020-0680-1","article-title":"Metabolic labeling\nand targeted modulation of dendritic cells","author":"Wang","year":"2020","journal-title":"Nat. Mater."},{"key":"2026081806103698500_cit18","doi-asserted-by":"publisher","first-page":"1970336","DOI":"10.1002\/adfm.201970336","article-title":"Multiantigenic Nanoformulations\nActivate Anticancer\nImmunity Depending on Size","volume":"29","author":"Li","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"2026081806103698500_cit19","doi-asserted-by":"publisher","first-page":"1706098","DOI":"10.1002\/adma.201706098","article-title":"A Dual Immunotherapy\nNanoparticle Improves T-Cell Activation and Cancer Immunotherapy","volume":"30","author":"Mi","year":"2018","journal-title":"Adv. Mater."},{"key":"2026081806103698500_cit20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41565-018-0146-7","article-title":"Combination of fucoidan-based\nmagnetic nanoparticles and immunomodulators enhances tumour-localized\nimmunotherapy","volume":"13","author":"Chiang","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"2026081806103698500_cit21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/anie.201804882","article-title":"Nanoparticle-Mediated\nImmunogenic\nCell Death Enables and Potentiates Cancer Immunotherapy","volume":"58","author":"Duan","year":"2019","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026081806103698500_cit22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nnano.2017.52","article-title":"A STING-activating nanovaccine for\ncancer immunotherapy","volume":"12","author":"Luo","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"2026081806103698500_cit23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41563-018-0028-2","article-title":"A facile approach to enhance antigen\nresponse for personalized\ncancer vaccination","volume":"17","author":"Li","year":"2018","journal-title":"Nat. Mater."},{"key":"2026081806103698500_cit24","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1021\/acs.nanolett.6b01994","article-title":"Acid-Activatable\nVersatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic\nImmunotherapy","volume":"16","author":"Wang","year":"2016","journal-title":"Nano Lett."},{"key":"2026081806103698500_cit25","doi-asserted-by":"publisher","first-page":"1805888","DOI":"10.1002\/adma.201805888","article-title":"Tumor Microenvironment-Activatable\nProdrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining\nImmunogenic Cell Death Induction and CD47 Blockade","volume":"31","author":"Zhou","year":"2019","journal-title":"Adv. Mater."},{"key":"2026081806103698500_cit26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1021\/acs.nanolett.9b04012","article-title":"Sheddable Prodrug Vesicles Combating\nAdaptive Immune Resistance for Improved Photodynamic Immunotherapy\nof Cancer","volume":"20","author":"Gao","year":"2020","journal-title":"Nano Lett."},{"key":"2026081806103698500_cit27","doi-asserted-by":"publisher","first-page":"eaaw6870","DOI":"10.1126\/sciadv.aaw6870","article-title":"Red blood\ncell-derived nanoerythrosome for antigen delivery with enhanced cancer\nimmunotherapy","volume":"5","author":"Han","year":"2019","journal-title":"Sci. Adv."},{"key":"2026081806103698500_cit28","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41467-017-01050-0","article-title":"Hollow MnO2 as a tumor-microenvironment-responsive\nbiodegradable nano-platform for combination therapy favoring antitumor\nimmune responses","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"key":"2026081806103698500_cit29","doi-asserted-by":"publisher","first-page":"16686","DOI":"10.1021\/jacs.6b09538","article-title":"Photodynamic Therapy\nMediated by Nontoxic Core-Shell Nanoparticles\nSynergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity\nand Antimetastatic Effect on Breast Cancer","volume":"138","author":"Duan","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"2026081806103698500_cit30","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1021\/acsnano.5b07706","article-title":"Intracellularly Acid-Switchable Multifunctional\nMicelles for Combinational Photo\/Chemotherapy of the Drug-Resistant\nTumor","volume":"10","author":"Wang","year":"2016","journal-title":"ACS Nano"},{"key":"2026081806103698500_cit31","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1021\/acs.nanolett.7b02031","article-title":"Acidity-Triggered\nLigand-Presenting\nNanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors","volume":"17","author":"Wang","year":"2017","journal-title":"Nano Lett."},{"key":"2026081806103698500_cit32","doi-asserted-by":"publisher","first-page":"1706759","DOI":"10.1002\/adma.201706759","article-title":"Cell Membrane\nCoating\nNanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"2026081806103698500_cit33","doi-asserted-by":"publisher","first-page":"0011","DOI":"10.1038\/s41551-016-0011","article-title":"In situ activation of platelets with checkpoint inhibitors for post-surgical\ncancer immunotherapy","volume":"1","author":"Wang","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"2026081806103698500_cit34","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1021\/acs.nanolett.9b00021","article-title":"Reprogramming\nTumor Immune Microenvironment (TIME) and Metabolism via Biomimetic\nTargeting Codelivery of Shikonin\/JQ1","volume":"19","author":"Wang","year":"2019","journal-title":"Nano Lett."},{"key":"2026081806103698500_cit35","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of\nnanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"2026081806103698500_cit36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","article-title":"Enzyme-activatable\npolymer-drug conjugate augments tumour penetration and treatment efficacy","volume":"14","author":"Zhou","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"2026081806103698500_cit37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nbt.4181","article-title":"Enhancing\nT cell therapy through TCR-signaling-responsive nanoparticle drug\ndelivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"2026081806103698500_cit38","doi-asserted-by":"publisher","first-page":"1902960","DOI":"10.1002\/adma.201902960","article-title":"Self-Amplified\nDrug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy","volume":"31","author":"Feng","year":"2019","journal-title":"Adv. Mater."},{"key":"2026081806103698500_cit39","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1021\/acs.accounts.9b00292","article-title":"The Chemistry of Boronic Acids in Nanomaterials for\nDrug Delivery","volume":"52","author":"Stubelius","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"2026081806103698500_cit40","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common\ntherapeutic target\nin cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat.\nRev. Drug Discovery"},{"key":"2026081806103698500_cit41","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1038\/s41467-019-11269-8","article-title":"Targeting photodynamic and photothermal therapy to the endoplasmic\nreticulum enhances immunogenic cancer cell death","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"2026081806103698500_cit42","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1021\/acsnano.5b07522","article-title":"High-Density\nLipoproteins: Nature\u2019s Multifunctional Nanoparticles","volume":"10","author":"Kuai","year":"2016","journal-title":"ACS Nano"},{"key":"2026081806103698500_cit43","doi-asserted-by":"publisher","first-page":"e1386829","DOI":"10.1080\/2162402X.2017.1386829","article-title":"Trial watch:\nImmunogenic cell death induction by anticancer chemotherapeutics","volume":"6","author":"Garg","year":"2017","journal-title":"Oncoimmunology"},{"key":"2026081806103698500_cit44","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1073\/pnas.1917891117","article-title":"Transdermal\ncold atmospheric plasma-mediated immune checkpoint blockade therapy","volume":"117","author":"Chen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026081806103698500_cit45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.biomaterials.2016.10.016","article-title":"Drug self-delivery\nsystems for cancer therapy","volume":"112","author":"Qin","year":"2017","journal-title":"Biomaterials"},{"key":"2026081806103698500_cit46","doi-asserted-by":"publisher","first-page":"1906605","DOI":"10.1002\/adfm.201906605","article-title":"Enhancing Triple\nNegative Breast Cancer Immunotherapy by ICG-Templated\nSelf-Assembly of Paclitaxel Nanoparticles","volume":"30","author":"Feng","year":"2020","journal-title":"Adv.\nFunct. Mater."},{"key":"2026081806103698500_cit47","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1038\/s41467-017-01651-9","article-title":"Nano-enabled pancreas cancer immunotherapy\nusing immunogenic cell death and reversing immunosuppression","volume":"8","author":"Lu","year":"2017","journal-title":"Nat. Commun."},{"key":"2026081806103698500_cit48","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.1021\/acsnano.8b05189","article-title":"Breast\nCancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic\nCell Death Stimulus Plus Interference in the IDO-1 Pathway","volume":"12","author":"Lu","year":"2018","journal-title":"ACS Nano"},{"key":"2026081806103698500_cit49","doi-asserted-by":"publisher","first-page":"119933","DOI":"10.1016\/j.biomaterials.2020.119933","article-title":"Tumor microenvironment-responsive prodrug nanoplatform via co-self-assembly\nof photothermal agent and IDO inhibitor for enhanced tumor penetration\nand cancer immunotherapy","volume":"242","author":"Liu","year":"2020","journal-title":"Biomaterials"}],"container-title":["Accounts of Chemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.accounts.0c00254","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/53\/9\/1761\/12266733\/ar0c00254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/53\/9\/1761\/12266733\/ar0c00254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:10:45Z","timestamp":1787047845000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/achre4\/article\/53\/9\/1761\/1266018\/Smart-Nanosized-Drug-Delivery-Systems-Inducing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,8,21]]},"published-print":{"date-parts":[[2020,9,15]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.accounts.0c00254","relation":{},"ISSN":["0001-4842","1520-4898"],"issn-type":[{"value":"0001-4842","type":"print"},{"value":"1520-4898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]}}}